HIV Infections: all 4,342 studies
Page 21 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted DarunavirStatus unknownNCT02337322Phase 4
- Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAARTCompletedNCT02322827
- Effectiveness of Peer Navigation and Contingency Management on Retention in HIV CareCompletedNCT02310893Not applicable
- A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, TexasStatus unknownNCT02302950
- Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young WomenCompletedNCT02301507Not applicable
- Intermittent ART in Primary HIV InfectionCompletedNCT02300623Phase 4
- Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT02296541Phase 1
- REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical StudyStatus unknownNCT02291809Phase 2
- A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289495Phase 1
- A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289482Phase 1
- Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With MenCompletedNCT02287961Not applicable
- Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected ChildrenCompletedNCT02285478
- Facilitating HIV/AIDS and HIV Testing Literacy for Emergency Department PatientsStatus unknownNCT02284451Not applicable
- A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)CompletedNCT02277600Phase 1
- Food Effect Study With BMS-955176CompletedNCT02273947Phase 1
- Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral TreatmentCompletedNCT02269605Phase 1
- Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot StudyCompletedNCT02266992Phase 2
- Peripheral Arterial Insufficiency Associated With HIV/AIDSCompletedNCT02264509
- PRO 140 for Human Immunodeficiency Virus InfectionWithdrawnNCT02257788Phase 2
- Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected SubjectsCompletedNCT02251223Phase 1/2
- Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedNCT02249130Phase 2
- Improving Cervical Cancer Screening Among HIV-Infected Women in IndiaCompletedNCT02247999
- Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 PatientsTerminatedNCT02239835Phase 2
- Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV PatientsCompletedNCT02238314Phase 2
- Study on PharmacokineticsCompletedNCT02234882Phase 1
- The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive PatientsCompletedNCT02234492Phase 4
- Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic FailureCompletedNCT02232581Phase 2
- Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected AdultsStatus unknownNCT02231281Phase 3
- Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIVTerminatedNCT02229760Phase 1/2
- Reducing Proviral HIV DNA With Interferon-aStatus unknownNCT02227277Phase 2
- Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in ZimbabweStatus unknownNCT02216734Not applicable
- The Effect of an Enhanced Rice Bran Nutritional Supplement in HIVCompletedNCT02214173Not applicable
- The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure ProphylaxisCompletedNCT02211690Phase 4
- Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected AdultsCompletedNCT02207920Phase 1
- Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.CompletedNCT02206711Phase 1
- Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification StrategyCompletedNCT02199613Phase 4
- Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."CompletedNCT02196064
- Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected SubjectsCompletedNCT02194179Phase 1
- Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan AfricaCompletedNCT02192658
- Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected SubjectsCompletedNCT02191657Phase 1
- Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy RegimenCompletedNCT02191332
- Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) RegimensCompletedNCT02191319
- Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®CompletedNCT02191293
- Clinical and Therapeutic Evaluation of the Infection by HIV/AIDSCompletedNCT02191215
- Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological SuppressionCompletedNCT02191202
- Clinical Performance of Reveal G4 Rapid HIV-1 Antibody TestCompletedNCT02190578Not applicable
- Botswana Vitamin D Supplementation Study in HIV/AIDSCompletedNCT02189902Phase 3
- Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy VolunteersCompletedNCT02185300Phase 1
- Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected PatientsCompletedNCT02184299Phase 4
- Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected PatientsTerminatedNCT02184286Phase 1
- Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ PatientsCompletedNCT02184078Phase 4
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected WomenCompletedNCT02182791Phase 1
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive AdultsTerminatedNCT02182765Phase 1
- Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive PatientsCompletedNCT02181946Phase 4
- Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive WomenCompletedNCT02181933Phase 3
- DuoPACT Pilot InterventionCompletedNCT02181881Not applicable
- Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionCompletedNCT02170246Phase 1
- PrEPared and Strong: Clinic-Based PrEP for Black MSMCompletedNCT02167386Phase 4
- Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV InfectionCompletedNCT02166502
- Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected AdultsCompletedNCT02165267Phase 1
- Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy SubjectsCompletedNCT02164812Phase 1
- Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529CompletedNCT02164045Phase 1
- Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected SubjectCompletedNCT02159599Phase 4
- Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female SubjectsCompletedNCT02159131Phase 1
- Study of Combined Oral Contraceptive Effects in Female SubjectsCompletedNCT02157467Phase 1
- Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected SubjectsCompletedNCT02154360Phase 1
- PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5CompletedNCT02149888Phase 4
- Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in IndiaCompletedNCT02148094Early Phase 1
- COMO: Cognition Study With HIV+ Patients (CTNPT 015)TerminatedNCT02144688Early Phase 1
- DASH - Decision Making in Adolescent Sexual HealthTerminatedNCT02141646Not applicable
- IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV PersistenceCompletedNCT02140944
- Drug-drug Interaction (DDI) RifabutinCompletedNCT02138084Phase 1
- Asha Improving Health and Nutrition of Indian Women With AIDS and Their ChildrenCompletedNCT02136082Not applicable
- Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV InfectionTerminatedNCT02134886Phase 1
- Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in AdolescentsCompletedNCT02134431
- Improving Drug Adherence Among Adolescents in Uganda Using SMS RemindersCompletedNCT02128087Not applicable
- Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infectionCompletedNCT02125500Phase 2
- Medication Adherence in Human Immunodeficiency Virus (HIV)CompletedNCT02119390Not applicable
- Antiretroviral Adherence and Quality-of-life Support for HIV+ Patients in India With Twice-daily Interactive Voice Response (IVR) Calls With Health and Mental Health Messaging Compared to Weekly IVR Survey Only Control Condition: The Mobile-messaging Adherence and Support for Health Study, India.CompletedNCT02118454Not applicable
- Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002CompletedNCT02118168
- DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice ClientsCompletedNCT02116179Not applicable
- Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV PatientsCompletedNCT02113865
- Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy AdultsCompletedNCT02109354Phase 1
- Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionTerminatedNCT02109224Phase 1
- Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral TherapyCompletedNCT02098525
- Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral TherapyStatus unknownNCT02097381Not applicable
- Relative Bioavailability Study With BMS-955176CompletedNCT02095886Phase 1
- Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsCompletedNCT02082808Phase 1
- A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in GermanyCompletedNCT02076386
- Effects of an HIV Intervention Among Sex Workers in the PhilippinesCompletedNCT02071264Not applicable
- Dolutegravir + Rilpivirine Switch Study (DORISS)WithdrawnNCT02069834Phase 2/3
- Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult SubjectsCompletedNCT02064374Phase 1
- DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)CompletedNCT02063360Phase 1
- A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult SubjectsCompletedNCT02059031Phase 1
- Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected PatientsStatus unknownNCT02057003
- Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).CompletedNCT02054286Phase 1/2
- Pediatric Enhanced Surveillance StudyCompletedNCT02043769
- A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004CompletedNCT02042248Phase 1
- Intervention to Enhance PrEP Uptake and Adherence in a Community-Based SettingCompletedNCT02037594Not applicable
- Assessment of Group Peer Support to Children With HIV in VietnamStatus unknownNCT02035969Not applicable